SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-06-100495
Filing Date
2006-05-04
Accepted
2006-05-04 17:09:48
Documents
9
Period of Report
2006-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 470215
2 LICENSE AGREEMENT dex101.htm EX-10.1 193594
3 PURCHASE AND SALE AGREEMENT AND JOINT ESCROW INSTRUCTIONS dex102.htm EX-10.2 165614
4 FIRST AMENDMENT TO PURCHASE AND SALE AGREEMENT AND JOINT ESCROW INSTRUCTIONS dex103.htm EX-10.3 12016
5 CERTIFICATION OF CEO dex311.htm EX-31.1 7554
6 CERTIFICATION OF CFO dex312.htm EX-31.2 7409
7 CERTIFICATION OF CEO dex321.htm EX-32.1 3376
8 GRAPHIC g51781img_001.jpg GRAPHIC 2026
9 GRAPHIC g51781img_002.jpg GRAPHIC 1302
  Complete submission text file 0001193125-06-100495.txt   866040
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 06809367
SIC: 2834 Pharmaceutical Preparations